Several companies voluntarily recall extended release metformin in US due to exceeding nitrosodimethylamine (NDMA) threshold

FDA is alerting patients and health care professionals in US to several voluntary recalls of extended release metformin due to possibility they could contain NDMA above acceptable intake limit. It has published a recalled metformin list with details about products recalled.


US Food and Drug Administration